Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 3—March 2019
Research

Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012–2017

Hyukmin Lee, Young Hee Suh, Sunhwa Lee, Yong-Kyun Kim, Mi-Soon Han, Hye Gyung Bae, Magnus Unemo1Comments to Author , and Kyungwon Lee1Comments to Author 
Author affiliations: Yonsei University College of Medicine, Seoul, South Korea (H. Lee, Y.H. Suh, K. Lee); Seegene Medical Foundation, Seoul (S. Lee); Samkwang Medical Laboratories, Seoul (Y.-K. Kim); U2 Clinical Laboratories, Seoul (M.-S. Han); Green Cross Laboratories, Yongin, South Korea (H.G. Bae); World Health Organization Collaborating Centre for Gonorrhoea and other STIs, Örebro University, Örebro, Sweden (M. Unemo)

Main Article

Table 3

Percentage of patients treated with each antimicrobial drug used against gonorrhea in South Korea, 2010–2017

Year % Patients
Fluoroquinolones* Spectinomycin Ceftriaxone Cefixime Other cephalosporin Penicillin G
2010 49.6 32.8 13.1 2.9 1.4 0.2
2011 51.4 29.2 14.6 3.7 0.8 0.2
2012 52.3 22.2 19.5 4.6 1.2 0.2
2013 47.0 23.9 23.1 4.6 1.3 0.2
2014 38.8 22.0 20.3 3.9 1.1 0.1
2015 39.3 17.7 23.0 4.5 1.1 0.1
2016 36.7 17.3 24.7 5.0 1.4 0.1
2017 26.7 16.0 30.5 6.6 1.7 0.1

*Mainly ciprofloxacin.

Main Article

1Joint senior authors.

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external